US Post News
  • Home
  • Stocks Trading
  • Analyst Snapshot
  • Market Summary
  • Financial Scores
No Result
View All Result
  • Home
  • Stocks Trading
  • Analyst Snapshot
  • Market Summary
  • Financial Scores
No Result
View All Result
US Post News
No Result
View All Result

What Drove Zhongchao (ZCMD) Stock Up 8.49% In After-Hour Trading On Wednesday?

October 27, 2022
in Analyst Snapshot

Despite the absence of any pertinent news, shares of Zhongchao Inc. (NASDAQ: ZCMD) rose 8.49% to $1.15 on Wednesday.

Do You Know The Best Place To Find Gains In Volatile Markets?

In today's chaotic marketplace, the biggest gains will come from some currently-small companies that pass by older, larger businesses still stuck in a pre-pandemic world. The trick is figuring out which small caps will be tomorrow's winners. That's why StockWire News has put together a special Wealth Building Report, highlighting 3 small cap stocks set to soar in 2023.

Click here for full details and to join for free.

Sponsored

What then has caused ZCMD stock to increase?

As the ZCMD stock increased despite the lack of recent news, we can then highlight recent developments to give a more comprehensive knowledge of the firm. Chongqing Xinjiang Pharmaceutical Co., Ltd. (“Xinjiang Pharmaceutical”), a recent creation of Zhongchao (ZMCD), specializes in the import and export of pharmaceuticals, OME (original equipment manufacturer) production, the operation of medical supplies, and pharmaceutical online services. ZCMD anticipates strengthening and expanding its “Medical-Pharmaceutical-Patient” business model since Xinjiang Pharmaceutical is crucial in providing patients with high-quality pharmaceuticals.

In order to address the rising need for patient-centered healthcare in China, Zhongchao has taken a few measures to transform its business model from “Medical-Pharmaceutical” to “Medical-Pharmaceutical-Patient.” ZCMD launched Xinjiang Pharmaceutical to work toward attaining drug accessibility and affordability for those patients, which was followed by the development of Zhixun Internet Hospital to offer standardized internet healthcare services for patients with cancer or other serious conditions.

How will ZCMD benefit from this?

To facilitate the supply of medications from pharmaceutical factories to retail locations, Xinjiang Pharmaceutical intends to work with Zhixun Online Hospital and other internet hospitals to create a 2B2C (to business and to customer) pharmaceutical procurement platform. With this strategy, Xinjiang Pharmaceutical will be able to provide high-quality, cost-effective medications both domestically and internationally, increasing medicine accessibility and reducing medication costs.

The founding of Xinjiang Pharmaceutical is a crucial step for ZCMD in enhancing its “Medical-Pharmaceutical-Patient” paradigm in the area of cancer and other serious illnesses. In order to improve patient access to and affordability of medications, ZCMD anticipated using its existing networks and resources with pharmaceutical firms to create a pharmaceutical service system across the whole industrial chain.

Another step by ZCMD:

Zhixun Internet Hospital (Liaoning) Co., Ltd., a subsidiary of Zhongchao (ZCMD), was just established to offer patients with cancer or other serious conditions standardized Internet healthcare services. In order to further enhance its patient care services in the areas of cancer and serious illnesses, ZCMD must take this essential next step.

Leave a Reply Cancel reply

Your email address will not be published. Required fields are marked *

Related News

Results from Alkami Technology Inc. (ALKT) show potential

March 15, 2023

Cyclo Therapeutics Inc. (CYTH) can excel with these strategies

March 21, 2023

The RedHill Biopharma Ltd. (RDHL) Stock Is Headed for a Correction

March 14, 2023

“US Post News” – one of the oldest and most authoritative news sites in America. It was established in 1992, journalists, photographers, correspondents, researchers came to the publication from the editorial offices of regional newspapers, drama theater, etc. They had no training, and they gained experience and skill in the process of work.

Contact us: ceo@www.uspostnews.com

Catagories

  • Market Summary
  • Stocks Trading
  • Analyst Snapshot
  • Financial Scores

Company

  • Home
  • About US
  • Contact US

RECENT POSTS

  • The Battle of Fundamentals and Techniques: Bloom Energy Corporation (BE)
  • There Are Mixed Signals on the Chart for Sea Limited (SE)
  • Introducing Our Rant Against SoFi Technologies Inc.

Copyright © 2022 US Post News

No Result
View All Result
  • About US
  • Contact US
  • Home

Copyright © 2022 US Post News